India IPO Pipeline SEBI Regulatory Filings — February 07, 2026

No deviations or variations reported in IPO fund utilization for quarter and 9M ended Dec 31, 2025, vs prior periods, signaling strong management discipline post-listing

Neutral sentiment with low risk (low) and materiality (2/10) in BSE filing (Stock Code: 543861), consistent with stable post-IPO trajectory

Timely compliance disclosure on Feb 07, 2026, for Dec 31, 2025 period, ahead of typical cycles, reflects proactive governance

Board meeting scheduled Feb 14, 2026, for unaudited financial results Q ended Dec 31, 2025 (BSE: 503776), potential entry point ahead of results

Neutral sentiment and low risk in standard pre-results intimation, no adverse disclosures, supporting status quo performance

Reporting aligned with Q3 FY26 period ending Dec 31, 2025, comparable to Udayshivakumar's timeline, indicating synchronized post-IPO reporting

Both filings show zero insider trading activity or pledges reported, neutral management conviction post-IPO

No capital allocation changes (dividends, buybacks) disclosed, preserving flexibility for growth vs peers

Absence of forward-looking guidance cuts in intimation, maintaining positive outlook for results discussion

No M&A or transaction details, focusing on core IPO fund use without dilution risks

Low materiality (2/10 average) across both suggests minimal market impact, ideal for long-term holders

No operational metrics declines noted (e.g., volumes, costs), upholding post-IPO stability

No specific numerical details on IPO fund deployment provided despite no deviations, limiting visibility into efficiency

Standard disclosure without YoY/QoQ comparisons for 9M ended Dec 31, 2025, potential for unreported margin pressures

No preemptive financial metrics shared ahead of Feb 14 board meeting, risk of below-expectation Q3 FY26 results

Neutral rating with no bullish forward-looking statements, could signal flat QoQ performance vs Dec 31, 2025 period

Absence of debt-to-equity or ROE trends in filing, watch for leverage buildup post-IPO

No transactions or holdings updates disclosed, potential undetected selling pressure

Limited forward-looking data beyond Modipon board meet, risk of guidance downgrades in results

No dividend or buyback announcements, possible reinvestment delays vs growing cash post-IPO

No M&A or deal terms shared, opportunity cost if peers consolidate

Low materiality (2/10) across both may mask developing operational challenges in infra/manufacturing

No fund deviations for Q/9M Dec 31, 2025 offers confidence for accumulation at current levels

Board approval of Q3 FY26 results on Feb 14, 2026, could reveal outperformance vs silent peers

Timely BSE filing (Feb 07, 2026) positions as governance leader in IPO cohort

Aligned Dec 31, 2025 reporting with Udayshivakumar, potential relative upside if metrics beat neutral sentiment

Both at low risk level, attractive for defensive positioning in volatile IPO pipeline

Confirmed no variations supports thesis of undervalued infra play post-listing

Inter-alia agenda provides scope for positive surprises in unaudited results guidance

Absence of bearish signals creates alpha from mean reversion in post-IPO names

Upcoming full-year deviation statement as buy trigger if utilization accelerates

Outperforms Udayshivakumar on catalyst timing (Feb 14 vs static filing), trade ahead of results

2/2 filings are standard SEBI disclosures with no deviations (Udayshivakumar) or previews (Modipon), implying smooth listings; bullish for pipeline confidence

Both cover Dec 31, 2025 period, aggregate neutral sentiment signals stable cohort growth without margin erosion

Average 2/10 materiality across IPO listings, reduces volatility vs historical post-IPO dips; favors buy-and-hold

Only 1 scheduled event (Modipon Feb 14), highlights need for results-driven alpha in infra/manufacturing IPOs

No trading/pledges in either filing, common theme of high management conviction post-IPO vs historical selling

No buybacks/dividends but no dilutions, trend toward reinvestment in operations for 2026 growth

Approve unaudited Q ended Dec 31, 2025 results, watch for YoY/QoQ trends and guidance - Feb 14, 2026

Monitor Q4/June 2026 statement for utilization acceleration post Dec 31, 2025 no-deviation baseline

Post-board results dissemination via BSE, flag any margin/ROE shifts vs neutral sentiment

Watch for post-filing transactions/pledges around Stock Code 543861 holdings

Any targets/forecasts from Feb 14 meeting for FY26, compare to IPO prospectus

Scheduled events post-Dec 2025 results, potential dividend announcements

Future filings for capacity/volumes post-IPO fund use

Watch buyback/dividend approvals inter-alia at Feb 14 board meet